Monsenso A/S (CPH: MONSO)
Denmark
· Delayed Price · Currency is DKK 0.620
+0.030 (5.08%)
Sep 27, 2024, 4:48 PM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 41.98 million as of October 3, 2024. Its market cap has increased by 295.52% in one year.
Market Cap
41.98M
Enterprise Value
36.01M
Revenue
10.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.62
Market Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 41.98M, a decrease of -56.66%. That is a compound annual growth rate of -17.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2024 | 41.98M | 375.30% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | 163.08M | 68.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk A/S | 3,477.74B |
| Coloplast A/S | 196.96B |
| Genmab A/S | 101.20B |
| Zealand Pharma A/S | 57.86B |
| Demant A/S | 56.39B |
| H. Lundbeck A/S | 41.69B |
| H. Lundbeck A/S | 41.69B |
| ALK-Abelló A/S | 37.58B |